Funding

The group is currently supported by:

2020 - 2024    China Scholarship Council (CSC) stipend for Mr. Lin Cheng from Shanghai Xiaotong University

2020 - 2022    Förderung der medizinischen Fakultät der RWTH für die Generierung von Mikrogelen und Nanoträgern für Nukleinsäuren, 103,000 €, July 1, 2020, two years (granted to group member A.Jans)

2019 - 2021    Grant of the Wilhelm Sander foundation for the modulation of myeloid cells in hepatocarcinogenesis (grant no.2018.129.1), two years

2019 - 2022    Grant of the German Research Foundation for nanocarriers for small-non coding RNA to treat liver diseases, three years

2019 - 2020    Long term stipend with the German Academic Exchange Service (DAAD) GERLS Call 2018/2019, for PhD student Asmaa Mostafa Abdelaal Mohamed, for 24 months (as host). RNA-based nanomedicines.

Completed research support:

COST Action BM1404 Mye-EUNITER which is part of the European Union Framework Program Horizon 2020 (http://www.mye-euniter.eu)

2016-2017: Wilhelm Sander Foundation The role of monocytic immune cells for hepatocarcinogenesis and releance of therapeutic modulation of CCR2-dependent invasion and differentiation

2014-2015: START-Programm der Medizinischen Fakultät der RWTH-Aachen

2007-2010: DFG fellow in the graduate school „Biointerface“